Janux Therapeutics Stock (NASDAQ: JANX) stock price, news, charts, stock research, profile.
Open | $43.48 |
Close | $43.99 |
Volume / Avg. | 415.72K / 796.47K |
Day Range | 42.81 - 45.00 |
52 Wk Range | 5.65 - 65.60 |
Market Cap | $2.28B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 14.1% |
Days to Cover | 7.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Janux Therapeutics (NASDAQ:JANX) through any online brokerage.
Other companies in Janux Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
There is no analysis for Janux Therapeutics.
Janux Therapeutics has a consensus price target of $64.63.
The stock price for Janux Therapeutics (NASDAQ: JANX) is $43.99 last updated July 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Janux Therapeutics.
Janux Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Janux Therapeutics.
Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.